administration of thyrotropin-releasing hormone (TRH) or T R H plus dexamethasone (DEX) to pregnant rats accelerates lung surfactant system development in late gestation, but paradoxically depresses the normal late gestational elevation in fetal lung antioxidant enzyme (AOE) activities (Pediatr Res 30522, 1991). In these present studies, we tested whether both prenatal hormonal treatments act to depress normal fetal lung AOE development by negative regulation of AOE gene expression. We used solution hybridization to quantitate the concentration of AOE mRNA. Results of the developmental studies revealed significantly decreased lung mRNA concentrations of copper-zinc superoxide dismutase, manganese superoxide dismutase, catalase, and glutathione peroxidase in late gestation a s a result of prenatal TRH treatment. The addition of DEX administration did not reverse the lowered expression of lung AOE genes due to T R H treatment, but instead resulted in significant additional decreases in pulmonary AOE mRNA levels a t both 21 and 22 d of gestation.The tested AOE mRNA half-lives (stabilities) revealed no significant differences between controls (8.0-10.5 h) and TRH-treated (8.2-9.5 h) and TRH-plus-DEX treatment (7.8-10.7 h) groups. These findings suggest that prenatal treatment with T R H and with T R H plus DEX acts to depress the normal late fetal lung AOE activity elevations by (direct) negative regulation of AOE gene expression, and the decreased AOE expression is likely regulated at the level of gene transcription rather than posttranscriptionally. (Pediatr Res 33: 171-176, 1993) Abbreviations AOE, antioxidant enzyme CuZnSOD, copper-zinc superoxide dismutase SOD, superoxide dismutase MnSOD, manganese superoxide dismutase CAT, catalase GP, glutathione peroxidase TRH, thyrotropin-releasing hormone T3, triiodothyronine DEX, dexamethasone cRNA, complementary RNA 2). It has been demonstrated in each of the five different species examined to date-the rat, rabbit, guinea pig, hamster. and sheep-that development of the surfactant system and the lung AOE system share a chronologically similar late gestational pattern of development, and that the developing lung markedly increases both its surfactant content and its AOE activity levels during the final I0 to 15% of gestation (3-6). The late gestational rise in AOE (SOD. CAT. and GP) activities is considered to be a normal "preparation for birth" phenomenon that is required to assure safe respiratory functioning of the newborn's lung when it is suddenly exposed to several-fold-higher O2 tension immediately after birth than the O2 tension experienced in We have previously demonstrated that. although prenatal administration of either T3 or T, plus DEX to pregnant rats accelerated surfactant system development in the late fetal lung, both of these hormonal treatments significantly delayed or decreased pulmonary AOE system development (8). Further studies were done recently using the same hormonal agents (TRH instead of T3) that are currently being tested clinically to try...